Biosimilars Market- Challenges & Prospects
The global biosimilars market alone is expected to reach $6.22 Billion by 2020 from $2.29 Billion in 2015, at a compound annual growth rate (CAGR) of 22.1% from 2015 to 2020. Geographically, the global biosimilars market is dominated by Europe, followed by Asia-Pacific, Rest of the World (RoW), and North America. However, the Asia-Pacific region is likely to witness the highest growth rate during the forecast period.
There are thought to be more biosimilar products currently in development across the Asia-Pacific region than anywhere else in the world, leading to wealth of opportunities for investigators and patients interested in taking part in biosimilar clinical trials. India, Japan, South Korea, and China are particularly active in biosimilar research efforts.
- Proving the ROI (Return On Investment) of marketing activities
- QBD (Quality By Design)
- Long Term Sustainability & PLC (Product Life Cycle)
- Future of next generation biosimilars
- SWOT Analysis of Biosimilars
- Challenging potential & Competing Vs Generics
- Investment sources and venture capitals
Related Conference of Biosimilars Market- Challenges & Prospects
Biosimilars Market- Challenges & Prospects Conference Speakers
Recommended Sessions
- BCS & IVIVC Based Biowaivers
- Biosimilars Analytical Strategies
- Biosimilars Market- Challenges & Prospects
- Biosimilars Research Pipeline
- Biosimilars- Hatch-Waxman Act & BPCI Act
- Challenges in Developing Biosimilars
- Clinical Studies on Biosimilars
- Cost Analysis of Biosimilars
- Current Developments in The Field of Biosimilars
- Emerging Biosimilars in Therapeutics
- Emerging Trends in Biosimilars
- Entrepreneurs Investment Meet
- Globalization of Biosimilars
- Latest Biosimilars in Asian Scenario
- Pharmacovigilance of Biosimilars